Medication info
Ricadren Plus Tablets

Ricadren Plus Tablets

Prescription medicationTabletOral
Ingredient · strength
Risedronate Sodium 2.5 Hydrate›40.162mg / 1 tabletCholecalciferol Concentrate Powder›56mg / 1 tablet
Manufacturer / importer
Teragen Etex Co., Ltd.
Appearance
Light orange oval film-coated tablet
Packaging
4 tablets/PTP
Approval status
Active

MFDS item code 201604698 · Approved 2016.07.29 · Insurance code 698503520

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men
Who takes it
Adults · Children
Adult dose
1. Adults: Administer 1 tablet orally once weekly 2. Older adults: No dose adjustment is necessary because the bioavailability and pharmacokinetics of this medicine in older adults (60 years and older) are similar to those in younger people. 4. Patients with renal impairment: No dose adjustment is necessary for patients with a creatinine clearance of 30ml/min or greater. This medicine is contraindicated in patients with severe renal impairment and a creatinine clearance of less than 30ml/min. Food interferes with the absorption of this medicine, so take it as follows to ensure adequate absorption. Take it at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after consuming food or beverages. To help the medicine reach the stomach easily and reduce the possibility of esophageal irritation, take it while sitting or standing upright with plenty of plain water (170 ~ 230ml). Taking it with other beverages, including mineral water, may reduce the absorption of this medicine. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should also not lie down for at least 30 minutes after taking it. Patients with inadequate calcium and vitamin D intake from food should take supplements. Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing homes, and patients with chronic illnesses) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements; measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. Taking this medicine once weekly provides one week’s supply of vitamin D at 800 IU daily. If a patient forgets to take a dose on the scheduled day, take it on the day they remember. Take the next dose again on the originally scheduled day. Do not take 2 tablets on the same day.
Child dose
3. Children: The safety and efficacy in children and adolescents who are still growing have not been established.

Ingredients

Manufacturer
Teragen Etex Co., Ltd.

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men

  • Osteoporosis
View approved original text

This medication is used for the treatment and prevention of osteoporosis in both postmenopausal women and men.

How to take

Adult dose

1. Adults: Administer 1 tablet orally once weekly 2. Older adults: No dose adjustment is necessary because the bioavailability and pharmacokinetics of this medicine in older adults (60 years and older) are similar to those in younger people. 4. Patients with renal impairment: No dose adjustment is necessary for patients with a creatinine clearance of 30ml/min or greater. This medicine is contraindicated in patients with severe renal impairment and a creatinine clearance of less than 30ml/min. Food interferes with the absorption of this medicine, so take it as follows to ensure adequate absorption. Take it at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after consuming food or beverages. To help the medicine reach the stomach easily and reduce the possibility of esophageal irritation, take it while sitting or standing upright with plenty of plain water (170 ~ 230ml). Taking it with other beverages, including mineral water, may reduce the absorption of this medicine. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should also not lie down for at least 30 minutes after taking it. Patients with inadequate calcium and vitamin D intake from food should take supplements. Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing homes, and patients with chronic illnesses) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements; measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. Taking this medicine once weekly provides one week’s supply of vitamin D at 800 IU daily. If a patient forgets to take a dose on the scheduled day, take it on the day they remember. Take the next dose again on the originally scheduled day. Do not take 2 tablets on the same day.

Child dose

3. Children: The safety and efficacy in children and adolescents who are still growing have not been established.

Precautions

This medicine may cause irritation to the stomach and esophagus, leading to issues such as esophagitis, esophageal ulcers, and esophageal erosion. It may sometimes worsen into esophageal obstruction or perforation, so if symptoms such as difficulty swallowing, pain behind the sternum, or heartburn occur during use, stop taking it immediately and consult a doctor. It is crucial to take this medication with a sufficient amount of water and not to lie down for at least 30 minutes after taking it, as understanding the proper method of ingestion is very important. Patients with mental disorders require special supervision while taking this medication. Patients with esophageal conditions, gastritis, duodenitis, or ulcers should exercise caution when using this drug. Furthermore, patients with esophageal strictures or achalasia, those who are hypersensitive to the ingredients of this drug, individuals with hypocalcemia, patients who cannot sit or stand for more than 30 minutes, or those with severe renal impairment should not take this drug. During treatment, various adverse reactions, including infections, back pain, muscle pain, indigestion, diarrhea, headaches, rashes, and itching, may occur. If symptoms are severe or persistent, consult a healthcare professional. This medication may interfere with absorption when taken with other drugs or foods containing divalent cations such as calcium, magnesium, and iron, so maintain an interval between doses. Additionally, supplementation with calcium and vitamin D may be necessary, particularly for patients undergoing long-term steroid treatment. Pregnant or breastfeeding women should avoid taking this medication or consult a physician, and safety in pediatric patients has not been established. Elderly patients should also be monitored closely, but in general, safety and efficacy are similar to those in younger patients. In case of overdose, blood calcium and phosphate levels may decrease, so be aware of symptoms of hypocalcemia, and reduce absorption if necessary using milk or calcium-containing antacids. This medicine should be stored out of reach of children, and it is advisable not to transfer it to another container.

Side effects

esophagitis, esophageal ulcer, esophageal erosion, esophageal obstruction, perforation, bleeding, gastric ulcer, duodenitis, glossitis, petechiae, anemia, arthralgia, joint abnormalities, myalgia, bone pain, bone abnormalities, leg cramps, bursitis, tendon abnormalities, depression, dizziness, insomnia, anxiety, neuralgia, vertigo, tension increase, sensory abnormalities, pharyngitis, rhinitis, dyspnea, pneumonia, rash, pruritus, skin cancer, cataract, conjunctivitis, otitis media, urinary tract infection, cystitis, injury from accident, epidemic cold syndrome, headache, overdose, allergic reaction, syncope, vasodilation, constipation, dyspepsia, nausea, vomiting, dry mouth, peripheral edema, traumatic fracture, myopathy, arthritis, bronchitis, sinusitis, increased cough, fever, falling, dizziness, bronchitis, sinusitis, increased cough, facial edema, hair loss, olfactory disturbance, Stevens-Johnson syndrome, toxic epidermal necrolysis, angioedema, blister, jawbone necrosis, liver dysfunction, jaundice, osteonecrosis of the external auditory canal, anorexia, myalgia, abdominal pain, weakness, heartburn, epigastric pain, discomfort in the chest, palpitations, increased sweating, facial flushing, burning sensation, kidney stones, belching, hematuria, fever, fatty liver, increased serum alkaline phosphatase

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it must be stored in a tightly sealed container. The storage temperature should be maintained at room temperature between 1°C and 30°C. This will help maintain the drug's effectiveness and safety.

Appearance and packaging

Appearance

Light orange oval film-coated tablet

Package unit

4 tablets/PTP

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.